Premium Pamabrom API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Pamabrom (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Mild Diuretic / Xanthine Derivative

Indications: Premenstrual Edema, Water Retention, and Bloating

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Pamabrom distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Pamabrom is a well-established, orally active Active Pharmaceutical Ingredient (API). In renal and reproductive pharmacology, it is classified as a mild diuretic. For pharmaceutical manufacturers, particularly those focusing on over-the-counter (OTC) women's health portfolios, this API is a highly sought-after raw material for the treatment of premenstrual syndrome (PMS) symptoms.

Chemically, Pamabrom is a water-soluble mixture composed of two distinct compounds in a 1:1 ratio: 8-bromotheophylline (a xanthine derivative) and 2-amino-2-methyl-1-propanol (which acts as a solubilizing agent).

At the physiological level, the 8-bromotheophylline component shares structural and functional similarities with other xanthines, such as caffeine and theophylline. It exerts its mild diuretic effect by acting directly on the kidneys, promoting the excretion of excess sodium and water through increased urine volume. This mechanism effectively alleviates temporary water weight gain, reducing the physical discomfort associated with bloating, swelling, and feelings of fullness that primarily occur during premenstrual and menstrual periods.

For pharmaceutical formulation scientists, integrating this API enables the development of highly effective OTC diuretic therapeutics. In commercial manufacturing, Pamabrom is rarely formulated as a standalone product. Instead, it is most frequently compounded into multi-symptom oral solid dosage forms (typically 25 mg per unit) alongside analgesics like acetaminophen and antihistamines like pyrilamine maleate to provide comprehensive menstrual relief.

Sourcing Pamabrom in Pakistan: Morgan’s Supply Network

Developing and commercializing effective OTC multi-symptom formulations requires a highly resilient and traceable raw material pipeline. Procuring bulk diuretic APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and complex regulatory compliance. Sourcing Pamabrom Pakistan through Morgan’s localized distribution network mitigates these supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions for OTC product registration.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard batch or are scaling up a high-volume Pamabrom api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during complex multi-ingredient blending and direct compression processes.

Technical Specifications for QA & R&D

The Pamabrom API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial (USP/EP) standards.

• Chemical Name: 8-Bromo-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione compound with 2-amino-2-methyl-1-propanol (1:1)
• CAS Number: 606-04-2
• Appearance: White to almost white crystalline solid powder
• Molecular Formula: C11H18BrN5O3
• Molecular Weight: 348.20 g/mol
• Assay / Purity (HPLC): ≥ 98.0% - 102.0% (Calculated on an anhydrous basis)
• Solubility Profile: Freely soluble in water; slightly soluble in alcohol. Detailed solubility parameters and pH limits of aqueous solutions are documented in the technical data sheet to assist your analytical R&D teams with wet granulation stability and dissolution profiling.

Manufacturing and Handling Guidelines for Formulators

Pamabrom is a safe, OTC-approved pharmacological compound when formulated correctly, but raw API handling requires standard industrial safety compliance to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and moisture uptake.
• Occupational Safety: Personnel handling the pure API powder must follow standard industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks, chemical-resistant nitrile gloves, and protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated weighing booths to prevent the inhalation of airborne particulates and cross-contamination with other active ingredients.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.